Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry (Q44438122)

3 December 2017

Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry (English)

1 reference

3 December 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742575

1 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0166-3542(02)00210-3

1 January 2024

Mary C. Long

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742575

1 January 2024

Deborah J. Bidanset

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742575

1 January 2024

Stephanie L. Williams

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742575

1 January 2024

Nicole L. Kushner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742575

1 January 2024

Earl R. Kern

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742575

1 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12742575

1 January 2024

publication date

1 April 2003

1 reference

full work available at URL

3 December 2017

https://api.elsevier.com/content/article/PII:S0166354202002103?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0166-3542(02)00210-3

https://api.elsevier.com/content/article/PII:S0166354202002103?httpAccept=text/plain

1 January 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0166-3542(02)00210-3

1 January 2024

1 reference

3 December 2017

58

1 reference

3 December 2017

2

1 reference

3 December 2017

149-157

1 reference

Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6)

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

In vitro sensitivity of human herpesvirus-6 to antiviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Flow cytometric evaluation of antiviral agents against human herpesvirus 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Effect of acyclovir on infectious mononucleosis: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

1 reference

7 January 2021

Plaque-associated expression of human herpesvirus 6 in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Acyclovir efficiently inhibits oropharyngeal excretion of Epstein-Barr virus in patients with acute infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Human herpesvirus 8 and Kaposi's sarcoma in persons infected with human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Detection of human herpesvirus-6 DNA in peripheral blood and saliva

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Human herpesviruses 6 and 7: identification of newly recognized viral pathogens and their association with human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Comparison of the anti-ebv titer and the ebv-associated membrane reactive and precipitating antibody levels in the sera of burkitt lymphoma and nasopharyngeal carcinoma patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Detection of two early gene products of Epstein-Barr virus by fluorescence flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Human herpesvirus 6 (HHV-6).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Inhibitory effects of novel nucleoside and nucleotide analogues on Epstein-Barr virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Human herpesvirus-6 in transplantation: an emerging pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Detection and quantification of Epstein-Barr virus EBER1 in EBV-infected cells by fluorescent in situ hybridization and flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Identification of human herpesvirus-6 as a causal agent for exanthem subitum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

The Epstein-Barr virus:host balance in acute infectious mononucleosis patients receiving acyclovir anti-viral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: characterization of antiherpesvirus agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900210-3

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference